Literature DB >> 2234440

Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant.

L Baca1, L Martinelli.   

Abstract

We report the lst case of neuroleptic malignant syndrome occurring in a patient receiving desipramine, a tricyclic antidepressant, with no exposure to neuroleptics. Our case suggests that this syndrome may be caused by a central imbalance between norepinephrine and dopamine, and not by dopamine depletion alone.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2234440     DOI： 10.1212/wnl.40.11.1797

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  3 in total

1.  Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia.

Authors:  E Stevens; A Roman; M Houa; D Razavi; N Jaspar
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

2.  Neuroleptic malignant syndrome and lithium carbonate.

Authors:  S Fava; A C Galizia
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

3.  MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis?

Authors:  T Becker; J Kornhuber; E Hofmann; M Weller; C Rupprecht; H Beckmann
Journal:  J Neural Transm Gen Sect       Date:  1992
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.